Anoat Therapeutics, a preclinical stage biotech company specialized in Cystic Fibrosis (CF), today announces it has raised €2 million in Seed funding from AdBio partners, a venture capital company specialized in seed investments in life sciences startups. This investment from the AFB FII fund stems from the AdBio-Inserm Transfert partnership announced in May 2022 to […]
The post Paris-based Anoat Therapeutics raises €2 million Seed to develop novel therapies for Cystic Fibrosis appeared first on EU-Startups.
Accedi per aggiungere un commento
Altri post in questo gruppo
Black Semiconductor, a pioneer in next-generation chip technology, announced €228.7 million round, one of the largest funding for a deep tech company manufacturing chips in Europe to date. The comp
Light, the creator of a fully automated general ledger for multinationals, has come out of stealth today with a €12.1 million seed round to scale the first AI-powered general ledger for automating
Rivia, a Swiss startup specializing in AI-driven analytics and clinical trial data infrastructure for Biotechs, has secured a €3 million seed funding round led by Speedinvest. The funds will be use
The startup landscape in 2024 has undergone a significant shift. A recent report from Pitchbook highlights that fewer rounds are taking place. Gone are the days of funding rounds fueled by inflated
Cognigy, a global leader in AI-first customer service automation, announced today that it has raised €93 million in Series C funding. The round was led by Eurazeo Growth, with participation from ex
The M. Demajo Group stands as a distinguished business entity in Malta, boasting a storied legacy of triumph in various sectors across numerous decades. Originally specializing in wine and spirits
Cardino, a pioneer in the used electric vehicle (EV) market, announced a €4 million seed funding round spearheaded by Point Nine. The funding round was supported by an array of distinguished angel
